Skip to main content
The British Journal of Ophthalmology logoLink to The British Journal of Ophthalmology
. 1992 Apr;76(4):246–247. doi: 10.1136/bjo.76.4.246

Lid melanoma and parkinsonism.

S A Haider 1, V T Thaller 1
PMCID: PMC504240  PMID: 1390497

Abstract

This is a case report of a patient with parkinsonism on levodopa therapy who developed a lid margin melanoma. The possible association is discussed.

Full text

PDF
246

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bernstein J. E., Medenica M., Soltani K., Solomon A., Lorincz A. L. Levodopa administration and multiple primary cutaneous melanomas. Arch Dermatol. 1980 Sep;116(9):1041–1044. [PubMed] [Google Scholar]
  2. Kochar A. S. Development of malignant melanoma after levodopa therapy for Parkinson's disease. Report of a case and review of the literature. Am J Med. 1985 Jul;79(1):119–121. doi: 10.1016/0002-9343(85)90555-8. [DOI] [PubMed] [Google Scholar]
  3. Lieberman A. N., Shupack J. L. Levodopa and melanoma. Neurology. 1974 Apr;24(4):340–343. doi: 10.1212/wnl.24.4.340. [DOI] [PubMed] [Google Scholar]
  4. Przybilla B., Schwab U., Landthaler M., Braun-Falco O. Development of two malignant melanomas during administration of levodopa. Acta Derm Venereol. 1985;65(6):556–557. [PubMed] [Google Scholar]
  5. Rampen F. H. Levodopa and melanoma: three cases and review of literature. J Neurol Neurosurg Psychiatry. 1985 Jun;48(6):585–588. doi: 10.1136/jnnp.48.6.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Skibba J. L., Pinckley J., Gilbert E. F., Johnson R. O. Multiple primary melanoma following administration of levodopa. Arch Pathol. 1972 Jun;93(6):556–561. [PubMed] [Google Scholar]
  7. Sober A. J., Wick M. M. Levodopa therapy and malignant melanoma. JAMA. 1978 Aug 11;240(6):554–555. [PubMed] [Google Scholar]
  8. Van Rens G. H., De Jong P. T., Demols E. E., Brihaye-Van Geertruyden M. F. Uveal malignant melanoma and levodopa therapy in Parkinson's disease. Ophthalmology. 1982 Dec;89(12):1464–1466. doi: 10.1016/s0161-6420(82)34616-3. [DOI] [PubMed] [Google Scholar]
  9. Wick M. M., Byers L., Frei E., 3rd L-dopa: selective toxicity for melanoma cells in vitro. Science. 1977 Jul 29;197(4302):468–469. doi: 10.1126/science.877570. [DOI] [PubMed] [Google Scholar]
  10. Wick M. M., Kramer R. A., Gorman M. Enhancement of L-dopa incorporation into melanoma by dopa decarboxylase inhibition. J Invest Dermatol. 1978 Jun;70(6):358–360. doi: 10.1111/1523-1747.ep12543559. [DOI] [PubMed] [Google Scholar]

Articles from The British Journal of Ophthalmology are provided here courtesy of BMJ Publishing Group

RESOURCES